Abstract
Taoyu Ye
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1016/j.cmet.2007.10.002
10.1016/j.cmet.2007.10.002
10.1158/0008-5472.can-17-2043
10.1158/0008-5472.can-17-2043
10.3322/caac.21492
10.3322/caac.21492
Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning
2020
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
10.1038/s41467-019-13825-8 · 2020
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
2020
10.1038/nm.4333
10.1038/nm.4333
A new fusion of grey wolf optimizer algorithm with a two-phase mutation for feature selection
10.1016/j.eswa.2019.112824 · 2020
10.1038/s41588-018-0167-z
10.1038/s41588-018-0167-z
Predicting cancer tissue-of-origin by a machine learning method using DNA somatic mutation data
10.3389/fgene.2020.00674 · 2020
TOOme: a novel computational framework to infer cancer tissue-of-origin by integrating both gene mutation and expression
2020
An enhanced deep learning approach for brain cancer MRI images classification using residual networks
10.1016/j.artmed.2019.101779 · 2020
Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas
10.3174/ajnr.a5667 · 2018
10.1038/s41467-017-02465-5
10.1038/s41467-017-02465-5
Deep feature learning for histopathological image classification of canine mammary tumors and human breast cancer
10.1016/j.ins.2019.08.072 · 2020
Deep-learning approach to identifying cancer subtypes using high-dimensional genomic data
10.1093/bioinformatics/btz769 · 2020
10.1371/journal.pcbi.1006826
10.1371/journal.pcbi.1006826
10.1038/s41591-018-0177-5
10.1038/s41591-018-0177-5
Identification of 12 cancer types through genome deep learning
2019
DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations
10.1186/s12859-016-1334-9 · 2016
10.3390/s19194207
10.3390/s19194207
10.1109/iccv.2017.74
10.1109/iccv.2017.74
Unresolved referenced work
2015
Unresolved referenced work
2016
Unresolved referenced work
2016
Unresolved referenced work
2017
10.1002/9781118548387
10.1002/9781118548387 · 2013
Unresolved referenced work
Kept as external metadata until matched
The condensed nearest neighbor rule (Corresp.)
10.1109/tit.1968.1054155 · 1968
10.1198/016214502753479248
10.1198/016214502753479248
Support-vector networks
10.1023/a:1022627411411 · 1995
A tutorial on support vector machines for pattern recognition
10.1023/a:1009715923555 · 1998
10.1023/a:1010933404324
10.1023/a:1010933404324
10.1214/aos/1013203451
10.1214/aos/1013203451
10.1007/978-3-030-00834-5_7
10.1007/978-3-030-00834-5_7
Unresolved referenced work
2015
10.1038/323533a0
10.1038/323533a0
10.1145/3233547.3233588
10.1145/3233547.3233588 · 2018
Visualizing data using t-SNE
2008
DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists
10.1093/nar/gkm415 · 2007
Engagement of renin-angiotensin system in prostate cancer
10.2174/156800911795538101 · doi-reference
Role of the renin–angiotensin system in prostate cancer
10.1016/j.mce.2008.08.032 · doi-reference
Renin-angiotensin system is an important factor in hormone refractory prostate cancer
10.1002/pros.20407 · doi-reference
10.1210/me.2006-0480
10.1210/me.2006-0480 · doi-reference
TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model
10.1371/journal.pone.0021650 · doi-reference
10.1038/nrc2402
10.1038/nrc2402 · doi-reference
10.1016/j.ccr.2010.03.018
10.1016/j.ccr.2010.03.018 · doi-reference
10.1158/2159-8290.cd-12-0085
10.1158/2159-8290.cd-12-0085 · doi-reference
10.1038/nrc3627
10.1038/nrc3627 · doi-reference
10.1007/s10555-011-9299-7
10.1007/s10555-011-9299-7 · doi-reference
Identification of key genes and multiple molecular pathways of metastatic process in prostate cancer
10.7717/peerj.7899 · doi-reference
Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer
10.1186/1477-7827-2-2 · doi-reference
Estrogen receptor signaling in prostate cancer: implications for carcinogenesis and tumor progression
10.1002/pros.23446 · doi-reference
A systematic study of the impact of estrogens and selective estrogen receptor modulators on prostate cancer cell proliferation
10.1038/s41598-020-60844-3 · doi-reference
10.1016/j.bbrc.2003.09.132
10.1016/j.bbrc.2003.09.132 · doi-reference
Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway
10.2174/156800909787580999 · doi-reference
10.1158/1078-0432.ccr-08-0125
10.1158/1078-0432.ccr-08-0125 · doi-reference
10.1002/(sici)1097-0045(19970215)30:33.0.co;2-j
10.1002/(sici)1097-0045(19970215)30:3<167::aid-pros4>3.0.co;2-j · doi-reference
HIF-1α and calcium signaling as targets for treatment of prostate cancer by cardiac glycosides
10.2174/156800909789760249 · doi-reference
Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma
10.1160/th03-11-0679 · doi-reference
Activation of Rap1 promotes prostate cancer metastasis
10.1158/0008-5472.can-08-4269 · doi-reference
Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancer
10.1158/1541-7786.mcr-08-0052 · doi-reference
10.1038/nrc1647
10.1038/nrc1647 · doi-reference
Olfactory receptors as biomarkers in human breast carcinoma tissues
10.3389/fonc.2018.00033 · doi-reference
10.1016/j.ccr.2010.05.026
10.1016/j.ccr.2010.05.026 · doi-reference
10.1002/ijc.22862
10.1002/ijc.22862 · doi-reference